Acenocoumarol (BioDeep_00000026772)

   

human metabolite blood metabolite


代谢物信息卡片


4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one

化学式: C19H15NO6 (353.08993300000003)
中文名称: 乙酰香豆酚
谱图信息: 最多检出来源 Homo sapiens(blood) 83.33%

分子结构信息

SMILES: CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(C3=CC=CC=C3OC2=O)O
InChI: InChI=1S/C19H15NO6/c1-11(21)10-15(12-6-8-13(9-7-12)20(24)25)17-18(22)14-4-2-3-5-16(14)26-19(17)23/h2-9,15,22H,10H2,1H3

描述信息

Acenocoumarol is a coumarin derivative used as an anticoagulant. Coumarin derivatives inhibit the reduction of vitamin K by vitamin K reductase. This prevents carboxylation of vitamin K-dependent clotting factors, II, VII, XI and X, and interferes with coagulation. Hematocrit, hemoglobin, international normalized ratio and liver panel should be monitored. Patients on acenocoumarol are prohibited from giving blood.
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists
D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

同义名列表

44 个代谢物同义名

4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one; 3-(alpha-(4-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin; 3-(alpha-(p-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin; 4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one; 3-(alpha-p-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin; 3-(Α-(4-nitrophenyl)-β-acetylethyl)-4-hydroxycoumarin; 3-(a-(4-Nitrophenyl)-b-acetylethyl)-4-hydroxycoumarin; 3-(Α-(p-nitrophenol)-β-acetylethyl)-4-hydroxycoumarin; 3-(a-(p-Nitrophenol)-b-acetylethyl)-4-hydroxycoumarin; 3-(Α-p-nitrophenyl-β-acetylethyl)-4-hydroxycoumarin; 3-(a-p-Nitrophenyl-b-acetylethyl)-4-hydroxycoumarin; 3-(alpha-Acetonyl-p-nitrobenzyl)-4-hydroxycoumarin; 3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin; 3-(Α-acetonyl-4-nitrobenzyl)-4-hydroxycoumarin; 3-(a-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin; 3-(Α-acetonyl-p-nitrobenzyl)-4-hydroxycoumarin; 3-(a-Acetonyl-p-nitrobenzyl)-4-hydroxycoumarin; Nitrophenylacetylethyl-4-hydroxycoumarine; Ciba geigy brand OF acenocoumarol; Ciba-geigy brand OF acenocoumarol; Novartis brand OF acenocoumarol; Alliance brand OF acenocoumarol; Acenocoumarol ciba-geigy brand; Acenocoumarol novartis brand; Acenocoumarol alliance brand; Acenocoumarolum; Nitrovarfarian; ACENOCOUMAROL; Nitrowarfarin; Acenocumarolo; Acenocoumarin; Mini-sintrom; Acenokumarin; Acenocumarol; Mini sintrom; MiniSintrom; Nicoumalone; Sinthrome; Syncoumar; Nicumalon; Synthrom; Syncumar; Sinkumar; Sintrom



数据库引用编号

11 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Alberto Lázaro-García, Inés Martínez-Alfonzo, Rosa Vidal-Laso, Diego Velasco-Rodríguez, Marta Tomás-Mallebrera, Marta González-Rodríguez, Pilar Llamas-Sillero. A journey through anticoagulant therapies in the treatment of left ventricular thrombus in post-COVID-19 heparin-induced thrombocytopenia: a case report. Hematology (Amsterdam, Netherlands). 2022 Dec; 27(1):318-321. doi: 10.1080/16078454.2022.2043572. [PMID: 35231200]
  • Metaxia Bareka, Maria P Ntalouka, Konstantina Kolonia, Antonios A Koutalos, Michael Hantes, Eleni Arnaoutoglou. Introducing the 'Bleeding Team': Urgent Reconstruction of an Open Fracture in a Patient Receiving Acenocoumarol: A Case Report. JBJS case connector. 2021 06; 11(2):. doi: 10.2106/jbjs.cc.20.00786. [PMID: 34166270]
  • Falmata Laouan Brem, Hammam Rasras, Noha El Ouafi, Zakaria Bazid. Acute myocardial infarction in a 41-year-old woman due to elevated factor VIII: a case report. The Pan African medical journal. 2021; 38(?):207. doi: 10.11604/pamj.2021.38.207.28011. [PMID: 33995813]
  • E Álvarez-Rodríguez, R González González, R Torres-Gárate, P López-Riquelme, I González Martil, V Abad Cuñado. [Learning with COVID-19: what about anticoagulation?]. Anales del sistema sanitario de Navarra. 2020 Aug; 43(2):251-254. doi: 10.23938/assn.0884. [PMID: 32865189]
  • José-Manuel Suárez-Peñaranda, Anna Minasyan, Laura Sainz-Gaspar, María-Dolores Sánchez-Aguilar. Resolution of acenocoumarol-associated calciphylaxis with drug withdrawal. The Australasian journal of dermatology. 2019 Aug; 60(3):e223-e226. doi: 10.1111/ajd.13006. [PMID: 30790279]
  • Pilar Taberner-Bonastre, Ana Moreno-Miralles, Isabel Quintana-Vargas, Juan Francisco Peris-Martí. Analysis of acenocoumarol and levofloxacin interaction in elderly institutionalized patients. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 2019 03; 43(2):53-55. doi: 10.7399/fh.11111. [PMID: 30848177]
  • M Kopytek, M Zabczyk, J Natorska, J Siudut, K P Malinowski, P Ptaszek, A Glajcar, T Goralczyk, A Undas. Viscoelastic properties of plasma fibrin clots are similar in patients on rivaroxaban and vitamin K antagonists. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. 2019 02; 70(1):. doi: 10.26402/jpp.2019.1.05. [PMID: 31019123]
  • Georgios Liagkos, Charalampos Spyropoulos, Christos Chouliaras, Gerasimos Tsourouflis, Gregory Kouraklis, Constantine E Vagianos. Management of blunt hepatic and splenic injuries (grade ≤ III) in patients receiving antithrombotic therapy. Annali italiani di chirurgia. 2019; 90(?):421-426. doi: NULL. [PMID: 31814603]
  • E Cristina Peláez, M-Carmen Estevez, Alejandro Portela, J-Pablo Salvador, M-Pilar Marco, Laura M Lechuga. Nanoplasmonic biosensor device for the monitoring of acenocoumarol therapeutic drug in plasma. Biosensors & bioelectronics. 2018 Nov; 119(?):149-155. doi: 10.1016/j.bios.2018.08.011. [PMID: 30125875]
  • Ruth María Sánchez Soriano, María Dolores Albero Molina, Carlos Israel Chamorro Fernández, Rocío Juliá-Sanchís, Ramón López Menchero, Carlos Del Pozo Fernández, Guillermo Grau Jornet, Julio Núñez Villota. Long-term prognostic impact of anticoagulation on patients with atrial fibrillation undergoing hemodialysis. Nefrologia. 2018 Jul; 38(4):394-400. doi: 10.1016/j.nefro.2017.11.026. [PMID: 29426785]
  • Sapan Kumar Behera, Alphienes Stanley Xavier, Sandhiya Selvarajan, Hemachandren Munuswamy, Satish Haridasan, Bheemanathi Hanuman Srinivas. Acenocoumarol as an alternative anticoagulant in a patient with warfarin-related nephropathy. British journal of clinical pharmacology. 2018 05; 84(5):1068-1071. doi: 10.1111/bcp.13541. [PMID: 29424022]
  • María Asunción Esteve-Pastor, José Miguel Rivera-Caravaca, Inmaculada Roldán-Rabadán, Vanessa Roldán, Javier Muñiz, Paula Raña-Míguez, Martín Ruiz-Ortiz, Ángel Cequier, Vicente Bertomeu-Martínez, Lina Badimón, Manuel Anguita, Gregory Y H Lip, Francisco Marín. Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry. Thrombosis and haemostasis. 2018 02; 118(2):279-287. doi: 10.1160/th17-06-0416. [PMID: 29443369]
  • Marta Broto, J Pablo Salvador, Roger Galve, M Pilar Marco. Biobarcode assay for the oral anticoagulant acenocoumarol. Talanta. 2018 Feb; 178(?):308-314. doi: 10.1016/j.talanta.2017.09.006. [PMID: 29136827]
  • Ahmadou M Jingi, Liliane Mfeukeu-Kuate, Aurel T Tankeu, Narcisse Assene Ateba, Edvine Wawo Yonta, Jean Jacques Noubiap. Challenges in the diagnosis and management of anti-phospholipid syndrome: a case from Cameroon. BMC research notes. 2017 Aug; 10(1):375. doi: 10.1186/s13104-017-2689-3. [PMID: 28789672]
  • Francisco Ignacio Torres-Bondia, Federico Javier Parada-Saavedra, Josep Manel Fernández-Armenteros, Joan Antoni Schoenenberger-Arnaiz. [Non-uremic calciphylaxis due to acenocoumarol]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 2017 Jul; 41(4):569-570. doi: 10.7399/fh.2017.41.4.10775. [PMID: 28683713]
  • Elena Mateos Egido, Attenya Álamo Medina, Ana Cristina Ródenas Gálvez, Marina Lombardero Pin, Alicia Díez Del Pino. [Sodium thiosulfate for the treatment of acenocumarol-induced calciphylaxis in a patient with preserved kidney function]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 2017 May; 41(3):425-427. doi: 10.7399/fh.2017.41.3.10693. [PMID: 28478757]
  • Zygmunt Warzecha, Paweł Sendur, Piotr Ceranowicz, Jakub Cieszkowski, Marcin Dembiński, Ryszard Sendur, Joanna Bonior, Jolanta Jaworek, Tadeusz Ambroży, Rafał Olszanecki, Beata Kuśnierz-Cabala, Kaczmarzyk Tomasz, Romana Tomaszewska, Artur Dembiński. Therapeutic Effect of Low Doses of Acenocoumarol in the Course of Ischemia/Reperfusion-Induced Acute Pancreatitis in Rats. International journal of molecular sciences. 2017 Apr; 18(4):. doi: 10.3390/ijms18040882. [PMID: 28430136]
  • Mário Góis, Ariana Azevedo, Fernanda Carvalho, Fernando Nolasco. Anticoagulant-related nephropathy in a patient with IgA nephropathy. BMJ case reports. 2017 Feb; 2017(?):. doi: 10.1136/bcr-2016-218748. [PMID: 28219912]
  • Seth Woodruff, Guillaume Feugère, Paula Abreu, Joseph Heissler, Marcia T Ruiz, Frank Jen. A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairment. Journal of thrombosis and thrombolysis. 2016 Nov; 42(4):494-504. doi: 10.1007/s11239-016-1386-8. [PMID: 27344439]
  • Zygmunt Warzecha, Paweł Sendur, Piotr Ceranowicz, Marcin Dembiński, Jakub Cieszkowski, Beata Kuśnierz-Cabala, Rafał Olszanecki, Romana Tomaszewska, Tadeusz Ambroży, Artur Dembiński. Protective Effect of Pretreatment with Acenocoumarol in Cerulein-Induced Acute Pancreatitis. International journal of molecular sciences. 2016 Oct; 17(10):. doi: 10.3390/ijms17101709. [PMID: 27754317]
  • W E van Spil, E Steenbergen, J C Verhave. A fatty cause of acute renal failure. The Netherlands journal of medicine. 2016 Oct; 74(8):365. doi: NULL. [PMID: 27762223]
  • Ravishankar Bhat, Àngela Ribes, Núria Mas, Elena Aznar, Félix Sancenón, M Dolores Marcos, Jose R Murguía, Abbaraju Venkataraman, Ramón Martínez-Máñez. Thrombin-Responsive Gated Silica Mesoporous Nanoparticles As Coagulation Regulators. Langmuir : the ACS journal of surfaces and colloids. 2016 Feb; 32(5):1195-200. doi: 10.1021/acs.langmuir.5b04038. [PMID: 26794474]
  • Timothy H Self, Ryan E Owens, Sami A Sakaan, Jessica L Wallace, Christopher W Sands, Amanda Howard-Thompson. Effect of diseases on response to vitamin K antagonists. Current medical research and opinion. 2016; 32(4):613-20. doi: 10.1185/03007995.2015.1134464. [PMID: 26695107]
  • Nienke van Rein, Willem M Lijfering, Mettine H A Bos, Martien H Herruer, Helga W Vermaas, Felix J M van der Meer, Pieter H Reitsma. Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists. PloS one. 2016; 11(12):e0164485. doi: 10.1371/journal.pone.0164485. [PMID: 27935941]
  • M L Becker, W P J Franken, F Karapinar, R Verzijl-Zeegers, T Schalekamp, R T M van der Hoeven. Possible drug-drug interaction between high-dose esomeprazole and phenprocoumon. European journal of clinical pharmacology. 2015 Dec; 71(12):1461-5. doi: 10.1007/s00228-015-1912-1. [PMID: 26400679]
  • Z Warzecha, P Sendur, P Ceranowicz, M Dembinski, J Cieszkowski, B Kusnierz-Cabala, R Tomaszewska, A Dembinski. Pretreatment with low doses of acenocoumarol inhibits the development of acute ischemia/reperfusion-induced pancreatitis. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. 2015 Oct; 66(5):731-40. doi: NULL. [PMID: 26579579]
  • Barbara Groszek, Paweł Piszczek. [Vitamin K antagonists overdose]. Przeglad lekarski. 2015; 72(9):468-71. doi: NULL. [PMID: 26827569]
  • Eduardo Anitua, María Troya, Mari Mar Zalduendo, Gorka Orive. The effect of different drugs on the preparation and biological outcomes of plasma rich in growth factors. Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft. 2014 Dec; 196(6):423-9. doi: 10.1016/j.aanat.2014.06.002. [PMID: 25053348]
  • Juan-Carlos Mejía, Gerard Espinosa, Dolors Tàssies, Joan-Carles Reverter, Ricard Cervera. Endogenous thrombin potential in Behçet's disease: relationship with thrombosis and anticoagulant therapy. Clinical and experimental rheumatology. 2014 Jul; 32(4 Suppl 84):S67-71. doi: NULL. [PMID: 25068444]
  • Vanessa Roldán, Francisco Marín, Sergio Manzano-Fernández, Pilar Gallego, Juan Antonio Vílchez, Mariano Valdés, Vicente Vicente, Gregory Y H Lip. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Journal of the American College of Cardiology. 2013 Dec; 62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. [PMID: 24055744]
  • V Roldán, F Marín, S Manzano-Fernandez, H Fernández, P Gallego, M Valdés, V Vicente, G Y H Lip. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?. Thrombosis and haemostasis. 2013 May; 109(5):956-60. doi: 10.1160/th13-01-0054. [PMID: 23572113]
  • V Samarasinghe, A M Marsland. Class action of oral coumarins in the treatment of a patient with chronic spontaneous urticaria and delayed-pressure urticaria. Clinical and experimental dermatology. 2012 Oct; 37(7):741-3. doi: 10.1111/j.1365-2230.2011.04281.x. [PMID: 22439898]
  • J Sasso, P Carmona, L Quiñones, M Ortiz, E Tamayo, N Varela, D Cáceres, I Saavedra. Bioequivalence of acenocoumarol in chilean volunteers: an open, randomized, double-blind, single-dose, 2-period, and 2-sequence crossover study for 2 oral formulations. Arzneimittel-Forschung. 2012 Aug; 62(8):395-9. doi: 10.1055/s-0032-1316290. [PMID: 22773430]
  • Aurel Constant Allabi, Yves Horsmans, Jean-Claude Alvarez, André Bigot, Roger K Verbeeck, Umit Yasar, Jean-Luc Gala. Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects. European journal of drug metabolism and pharmacokinetics. 2012 Jun; 37(2):125-32. doi: 10.1007/s13318-011-0056-7. [PMID: 21811894]
  • Wilbert S Aronow. Peripheral arterial disease of the lower extremities. Archives of medical science : AMS. 2012 May; 8(2):375-88. doi: 10.5114/aoms.2012.28568. [PMID: 22662015]
  • Zeynep Aydoğmuş, Ferhat Sarı, Sevgi Tatar Ulu. Spectrofluorimetric determination of aliskiren in tablets and spiked human plasma through derivatization with dansyl chloride. Journal of fluorescence. 2012 Mar; 22(2):549-56. doi: 10.1007/s10895-011-0988-y. [PMID: 21953437]
  • Michał Ząbczyk, Jacek Majewski, Jacek Lelakowski. Thromboembolic events are associated with prolonged clot lysis time in patients with permanent atrial fibrillation. Polskie Archiwum Medycyny Wewnetrznej. 2011 Nov; 121(11):400-7. doi: . [PMID: 22064373]
  • Job Harenberg, Roland Krämer, Christina Giese, Svetlana Marx, Christel Weiss, Martin Wehling. Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability. Journal of thrombosis and thrombolysis. 2011 Oct; 32(3):267-71. doi: 10.1007/s11239-011-0622-5. [PMID: 21811937]
  • Maria O Esmerian, Zahi Mitri, Mohammad-Zuheir Habbal, Eddy Geryess, Ghazi Zaatari, Samir Alam, Hadi N Skouri, Rami A Mahfouz, Ali Taher, Nathalie K Zgheib. Influence of CYP2C9 and VKORC1 polymorphisms on warfarin and acenocoumarol in a sample of Lebanese people. Journal of clinical pharmacology. 2011 Oct; 51(10):1418-28. doi: 10.1177/0091270010382910. [PMID: 21148049]
  • Mirjana K Kovac, Ljiljana B Rakicevic, Dragica P Radojkovic. Extreme sensitivity to acenocoumarol therapy in patient with both VKORC.-1639 A/A and CYP2C9*1/*3 genotypes. Journal of thrombosis and thrombolysis. 2011 Oct; 32(3):368-71. doi: 10.1007/s11239-011-0601-x. [PMID: 21638223]
  • Kinge van der Heide, Ann de Haes, Götz Jk Wietasch, Ans Cp Wiesfeld, Herman Gd Hendriks. Torsades de pointes during laparoscopic adrenalectomy of a pheochromocytoma: a case report. Journal of medical case reports. 2011 Aug; 5(?):368. doi: 10.1186/1752-1947-5-368. [PMID: 21838875]
  • Joris Deelen, Marian Beekman, Hae-Won Uh, Quinta Helmer, Maris Kuningas, Lene Christiansen, Dennis Kremer, Ruud van der Breggen, H Eka D Suchiman, Nico Lakenberg, Erik B van den Akker, Willemijn M Passtoors, Henning Tiemeier, Diana van Heemst, Anton J de Craen, Fernando Rivadeneira, Eco J de Geus, Markus Perola, Frans J van der Ouderaa, David A Gunn, Dorret I Boomsma, André G Uitterlinden, Kaare Christensen, Cornelia M van Duijn, Bastiaan T Heijmans, Jeanine J Houwing-Duistermaat, Rudi G J Westendorp, P Eline Slagboom. Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited. Aging cell. 2011 Aug; 10(4):686-98. doi: 10.1111/j.1474-9726.2011.00705.x. [PMID: 21418511]
  • Christof Geisen, Beate Luxembourg, Matthias Watzka, Stefan W Toennes, Katja Sittinger, Milka Marinova, Nicolas von Ahsen, Edelgard Lindhoff-Last, Erhard Seifried, Johannes Oldenburg. Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters. European journal of clinical pharmacology. 2011 Apr; 67(4):371-381. doi: 10.1007/s00228-010-0950-y. [PMID: 21110013]
  • Guangju Zhai, Alexander Teumer, Lisette Stolk, John R B Perry, Liesbeth Vandenput, Andrea D Coviello, Annemarie Koster, Jordana T Bell, Shalender Bhasin, Joel Eriksson, Anna Eriksson, Florian Ernst, Luigi Ferrucci, Timothy M Frayling, Daniel Glass, Elin Grundberg, Robin Haring, Asa K Hedman, Albert Hofman, Douglas P Kiel, Heyo K Kroemer, Yongmei Liu, Kathryn L Lunetta, Marcello Maggio, Mattias Lorentzon, Massimo Mangino, David Melzer, Iva Miljkovic, Alexandra Nica, Brenda W J H Penninx, Ramachandran S Vasan, Fernando Rivadeneira, Kerrin S Small, Nicole Soranzo, André G Uitterlinden, Henry Völzke, Scott G Wilson, Li Xi, Wei Vivian Zhuang, Tamara B Harris, Joanne M Murabito, Claes Ohlsson, Anna Murray, Frank H de Jong, Tim D Spector, Henri Wallaschofski. Eight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanisms. PLoS genetics. 2011 Apr; 7(4):e1002025. doi: 10.1371/journal.pgen.1002025. [PMID: 21533175]
  • Benny Sørensen, Donat R Spahn, Petra Innerhofer, Michael Spannagl, Rolf Rossaint. Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity. Critical care (London, England). 2011; 15(1):201. doi: 10.1186/cc9311. [PMID: 21345266]
  • Cristina Freitas, Mónica Fructuso, Maria João Rocha, Manuela Almeida, Sofia Pedroso, La Salete Martins, Leonídeo Dias, António Castro Henriques, Rui Almeida, António Cabrita. Late venous thrombosis of renal allograft: two cases with different treatment and outcome. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 2011; 31(1):115-7. doi: 10.3265/nefrologia.pre2010.sep.10641. [PMID: 21270927]
  • Beata Wożakowska-Kapłon, Radoslaw Bartkowiak, Urszula Grabowska, Grażyna Janiszewska. Persistent atrial fibrillation is not associated with thrombomodulin level increase in efficiently anticoagulated patients. Archives of medical science : AMS. 2010 Dec; 6(6):887-91. doi: 10.5114/aoms.2010.19297. [PMID: 22427762]
  • David Buttar, Nicola Colclough, Stefan Gerhardt, Philip A MacFaul, Scott D Phillips, Alleyn Plowright, Paul Whittamore, Kin Tam, Klaus Maskos, Stefan Steinbacher, Holger Steuber. A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions. Bioorganic & medicinal chemistry. 2010 Nov; 18(21):7486-96. doi: 10.1016/j.bmc.2010.08.052. [PMID: 20869876]
  • Artur A Antoniewicz, Slawomir Poletajew, Andrzej Biederman, Lukasz Zapala, Andrzej Borowka. Renal carcinoma infiltrating inferior vena cava and combined valvular heart disease--one-stage uro-cardiological procedure: a case report. World journal of surgical oncology. 2010 Jul; 8(?):63. doi: 10.1186/1477-7819-8-63. [PMID: 20667101]
  • András Antal, Zoltán Kovács, József Varga, László Horváth. [Rectus sheath hematomas caused by acenocumarol overdose]. Magyar sebeszet. 2010 Jun; 63(3):118-20. doi: 10.1556/maseb.63.2010.3.3. [PMID: 20570784]
  • Lars Maegdefessel, Joshua M Spin, Junya Azuma, Philip S Tsao. New options with dabigatran etexilate in anticoagulant therapy. Vascular health and risk management. 2010 May; 6(?):339-49. doi: 10.2147/vhrm.s8942. [PMID: 20531953]
  • Isabelle Fourel, Christophe Hugnet, Isabelle Goy-Thollot, Philippe Berny. Validation of a new liquid chromatography- tandem mass spectrometry ion-trap technique for the simultaneous determination of thirteen anticoagulant rodenticides, drugs, or natural products. Journal of analytical toxicology. 2010 Mar; 34(2):95-102. doi: 10.1093/jat/34.2.95. [PMID: 20223102]
  • Kyung Hee Choi, Ah Jeong Kim, In Ja Son, Kyung-Hwan Kim, Ki-Bong Kim, Hyuk Ahn, Eun Bong Lee. Risk factors of drug interaction between warfarin and nonsteroidal anti-inflammatory drugs in practical setting. Journal of Korean medical science. 2010 Mar; 25(3):337-41. doi: 10.3346/jkms.2010.25.3.337. [PMID: 20191029]
  • J Lasierra-Cirujeda, P Coronel, Mj Aza, M Gimeno. Use of sulodexide in patients with peripheral vascular disease. Journal of blood medicine. 2010; 1(?):105-15. doi: 10.2147/jbm.s10558. [PMID: 22282689]
  • Antonio V Gaddi, Arrigo Fg Cicero, Giovanni Gambaro. Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered. International journal of nephrology and renovascular disease. 2010; 3(?):99-105. doi: 10.2147/ijnrd.s5943. [PMID: 21694935]
  • Irena Baranowska, Piotr Markowski, Jacek Baranowski. Development and validation of an HPLC method for the simultaneous analysis of 23 selected drugs belonging to different therapeutic groups in human urine samples. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry. 2009 Nov; 25(11):1307-13. doi: 10.2116/analsci.25.1307. [PMID: 19907087]
  • X Delavenne, S Laporte, S Demasles, N Mallouk, T Basset, M Tod, P Girard, P Mismetti. Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid. Fundamental & clinical pharmacology. 2009 Feb; 23(1):127-35. doi: 10.1111/j.1472-8206.2008.00642.x. [PMID: 19267776]
  • Kerstin S Schick, Jan M Fertmann, Karl-Walter Jauch, Johannes N Hoffmann. Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Critical care (London, England). 2009; 13(6):R191. doi: 10.1186/cc8186. [PMID: 19948037]
  • Bernard Vigué. Bench-to-bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage - from theory to practice. Critical care (London, England). 2009; 13(2):209. doi: 10.1186/cc7701. [PMID: 19486503]
  • L M Fernández Herranz, R Arellano Gañán, P Garrido Abad, M I Jiménez Gálvez, Gloria Bocardo Fajardo, I Fernández González. [Wünderlich's syndrome related to spontaneous renal cyst rupture and anticoagulant therapy]. Actas urologicas espanolas. 2008 Sep; 32(8):861. doi: 10.1016/s0210-4806(08)73949-4. [PMID: 19013989]
  • John Danziger. Vitamin K-dependent proteins, warfarin, and vascular calcification. Clinical journal of the American Society of Nephrology : CJASN. 2008 Sep; 3(5):1504-10. doi: 10.2215/cjn.00770208. [PMID: 18495950]
  • H-L A Huang, S Vaidyanathan, C-M Yeh, M-N Bizot, H A Dieterich, W P Dole, D Howard. Effect of aliskiren, an oral direct renin inhibitor, on the pharmacokinetics and pharmacodynamics of a single dose of acenocoumarol in healthy volunteers. Current medical research and opinion. 2008 Sep; 24(9):2449-56. doi: 10.1185/03007990802285763. [PMID: 18662494]
  • A Kotsiou, E Diamanti, A Potamianou, H Parara, J Vovou, C Perisanidis, C Tes, C Tesseromatis. Anticoagulant-induced changes on antibiotic concentrations in the serum and bones. European journal of drug metabolism and pharmacokinetics. 2008 Jul; 33(3):173-9. doi: 10.1007/bf03191115. [PMID: 19007043]
  • J A Nuevo González, J C Cano Ballesteros, E Pintor Holguín, B Braun Saro, E Visús Soler, J A Sevillano Fernández. [Oral anticoagulation excess: analysis from an emergency department]. Revista clinica espanola. 2008 Feb; 208(2):66-70. doi: 10.1157/13115201. [PMID: 18261392]
  • Aránzazu González Canga, Ana M Sahagún Prieto, M José Diez Liébana, Nélida Fernández Martínez, Matilde Sierra Vega, Juan J García Vieitez. The pharmacokinetics and interactions of ivermectin in humans--a mini-review. The AAPS journal. 2008; 10(1):42-6. doi: 10.1208/s12248-007-9000-9. [PMID: 18446504]
  • Konstantinos X Siafakas, Efthimios D Avgerinos, Alexandros Papalampros, Theodossios Perdikides. Delayed 31st day traumatic hemothorax on acenocoumarol for aortic valve replacement. Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES. 2008 Jan; 14(1):70-2. doi: NULL. [PMID: 18306071]
  • M Mouhaoui, K Khaleq, K Yaqini, H Louardi. [Sublingual haematoma: an unusual complication of oral anticoagulation therapy: about one case]. Annales francaises d'anesthesie et de reanimation. 2008 Jan; 27(1):94-6. doi: 10.1016/j.annfar.2007.10.032. [PMID: 18160249]
  • Johanna H H van Geest-Daalderop, Barbara A Hutten, Nathalie C V Péquériaux, Hanneke J de Vries-Goldschmeding, Emmy Räkers, Marcel Levi. Invasive procedures in the outpatient setting: managing the short-acting acenocoumarol and the long-acting phenprocoumon. Thrombosis and haemostasis. 2007 Oct; 98(4):747-55. doi: 10.1160/th07-02-0086. [PMID: 17938797]
  • Johanna H H van Geest-Daalderop, Barbara A Hutten, Nathalie C V Péquériaux, Fred J L M Haas, Marcel Levi, Augueste Sturk. The influence on INRs and coagulation factors of the time span between blood sample collection and intake of phenprocoumon or acenocoumarol: consequences for the assessment of the dose. Thrombosis and haemostasis. 2007 Oct; 98(4):738-46. doi: 10.1160/th06-11-0645. [PMID: 17938796]
  • J J Castellanos Monedero, G Fernández Requeijo, M García Largacha, J I Molina Puente, J Barbera Farre. [Febrile syndrome in a 22-year old male]. Revista clinica espanola. 2007 Sep; 207(8):399-400. doi: 10.1157/13108758. [PMID: 17688867]
  • Anna Marcinkowska-Gapińska, Jacek Gapinski, Waldemar Elikowski, Feliks Jaroszyk, Leszek Kubisz. Comparison of three rheological models of shear flow behavior studied on blood samples from post-infarction patients. Medical & biological engineering & computing. 2007 Sep; 45(9):837-44. doi: 10.1007/s11517-007-0236-4. [PMID: 17674068]
  • W Pluskiewicz, J Zurek. Quantitative ultrasound and densitometric measurements and laboratory variables in patients on long-term acenocoumarol therapy. International journal of clinical practice. 2007 Aug; 61(8):1328-32. doi: 10.1111/j.1742-1241.2006.00906.x. [PMID: 17537183]
  • R González-Conejero, J Corral, V Roldán, F Ferrer, I Sánchez-Serrano, J J Sánchez-Blanco, F Marín, V Vicente. The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol. Journal of thrombosis and haemostasis : JTH. 2007 Aug; 5(8):1701-6. doi: 10.1111/j.1538-7836.2007.02630.x. [PMID: 17596133]
  • V Trompetas, E Yettimis, N Varsamidakis, N Courcoutsakis, E Kalokairinos. Endoscopic diagnosis and conservative management of an intramural sigmoid haematoma complicating anticoagulant therapy. Acta gastro-enterologica Belgica. 2007 Jul; 70(3):313-5. doi: NULL. [PMID: 18074749]
  • Gennaro Vecchione, Bruno Casetta, Michela Tomaiuolo, Elvira Grandone, Maurizio Margaglione. A rapid method for the quantification of the enantiomers of Warfarin, Phenprocoumon and Acenocoumarol by two-dimensional-enantioselective liquid chromatography/electrospray tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2007 May; 850(1-2):507-14. doi: 10.1016/j.jchromb.2006.12.050. [PMID: 17293173]
  • J-J Lehot, B Gostoli, P Ffrench, M Berruyer, M Hanss. [Treatment by lepirudin and acenocoumarol of heparin induced thrombocytopenia after valvular surgery: a word of caution]. Annales francaises d'anesthesie et de reanimation. 2006 Nov; 25(11-12):1140-3. doi: 10.1016/j.annfar.2004.05.022. [PMID: 17174212]
  • E B Wilms, R F Veldkamp, E van Meegen, D J Touw. [Partial resistance to acenocoumarol and phenprocoumon caused by enzyme polymorphism]. Nederlands tijdschrift voor geneeskunde. 2006 Sep; 150(38):2095-8. doi: NULL. [PMID: 17036862]
  • Daniel Serón. Management of cardiovascular risk in patients receiving calcineurin inhibitors--a case report. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2006 Jul; 21 Suppl 3(?):iii30-3. doi: 10.1093/ndt/gfl302. [PMID: 16815855]
  • Jens Voortman, Giuseppe Giaccone. Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report. BMC cancer. 2006 May; 6(?):129. doi: 10.1186/1471-2407-6-129. [PMID: 16689991]
  • Thomas Grobosch, Boris Angelow, Lena Schönberg, Dagmar Lampe. Acute bromadiolone intoxication. Journal of analytical toxicology. 2006 May; 30(4):281-6. doi: 10.1093/jat/30.4.281. [PMID: 16803669]
  • Raúl González-García, Guillermo Schoendorff, Mario F Muñoz-Guerra, Francisco J Rodríguez-Campo, Luis Naval-Gías, Jesús Sastre-Pérez. Upper airway obstruction by sublingual hematoma: a complication of anticoagulation therapy with acenocoumarol. American journal of otolaryngology. 2006 Mar; 27(2):129-32. doi: 10.1016/j.amjoto.2005.07.013. [PMID: 16500477]
  • Bernd Kammerer, Rainer Kahlich, Mike Ufer, Andreas Schenkel, Stefan Laufer, Christoph H Gleiter. Stereospecific pharmacokinetic characterisation of phenprocoumon metabolites, and mass-spectrometric identification of two novel metabolites in human plasma and liver microsomes. Analytical and bioanalytical chemistry. 2005 Nov; 383(6):909-17. doi: 10.1007/s00216-005-0113-7. [PMID: 16237546]
  • Mike Ufer. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol. Clinical pharmacokinetics. 2005; 44(12):1227-46. doi: 10.2165/00003088-200544120-00003. [PMID: 16372822]
  • Vanessa Roldán, Francisco Marín, Ana García-Herola, Gregory Y H Lip. Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation. Thrombosis research. 2005; 116(4):321-5. doi: 10.1016/j.thromres.2005.01.005. [PMID: 16038717]
  • Luis Eduardo Romero Nava, Aurora Belmont Gómez, Victor Manuel Vidal González. [Plasma and milk concentrations of acenocoumarin in breast-feeding women during post partum]. Ginecologia y obstetricia de Mexico. 2004 Nov; 72(?):550-60. doi: NULL. [PMID: 15986763]
  • Jesús M Cesar, Angel García-Avello, José L Navarro, María V Herraez. Aging and oral anticoagulant therapy using acenocoumarol. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 2004 Oct; 15(8):673-6. doi: 10.1097/00001721-200412000-00007. [PMID: 15613922]
  • C Muniesa, J Marcoval, A Moreno, S Giménez, J Sánchez, J R Ferreres, J Peyrí. Coumarin necrosis induced by renal insufficiency. The British journal of dermatology. 2004 Aug; 151(2):502-4. doi: 10.1111/j.1365-2133.2004.06121.x. [PMID: 15327563]
  • J F van der Heijden, B Rekké, B A Hutten, F J M van der Meer, M G H Remkes, M Vermeulen, H R Büller, P H Reitsma. Non-fatal major bleeding during treatment with vitamin K antagonists: influence of soluble thrombomodulin and mutations in the propeptide of coagulation factor IX. Journal of thrombosis and haemostasis : JTH. 2004 Jul; 2(7):1104-9. doi: 10.1111/j.1538-7836.2004.00768.x. [PMID: 15219193]
  • Sebastian Harder, Jochen Graff, Ute Klinkhardt, Nils von Hentig, Jeanine M Walenga, Hikari Watanabe, Masanori Osakabe, Hans-Klaus Breddin. Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effects on prothrombin time, activated partial thromboplastin time, and Ecarin Clotting Time. Thrombosis and haemostasis. 2004 Jun; 91(6):1137-45. doi: 10.1160/th03-12-0794. [PMID: 15175800]
  • H J G Desirée van den Bongard, Rolf W Sparidans, David J P Critchley, Jos H Beijnen, Jan H M Schellens. Pharmacokinetic drug-drug interaction of the novel anticancer agent E7070 and acenocoumarol. Investigational new drugs. 2004 Apr; 22(2):151-8. doi: 10.1023/b:drug.0000011791.75522.de. [PMID: 14739663]
  • Miranda R Andrus. Oral anticoagulant drug interactions with statins: case report of fluvastatin and review of the literature. Pharmacotherapy. 2004 Feb; 24(2):285-90. doi: 10.1592/phco.24.2.285.33137. [PMID: 14998226]
  • Thomas Hanslik, Jacques Prinseau. The use of vitamin K in patients on anticoagulant therapy: a practical guide. American journal of cardiovascular drugs : drugs, devices, and other interventions. 2004; 4(1):43-55. doi: 10.2165/00129784-200404010-00005. [PMID: 14967065]
  • Gangadhar Sunkara, Hilde Bigler, Yibin Wang, Harold Smith, Pratapa Prasad, James McLeod, Monica Ligueros-Saylan. The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol. Current medical research and opinion. 2004 Jan; 20(1):41-8. doi: 10.1185/030079903125002685. [PMID: 14741071]
  • Henk H W Thijssen, Bas Ritzen. Acenocoumarol pharmacokinetics in relation to cytochrome P450 2C9 genotype. Clinical pharmacology and therapeutics. 2003 Jul; 74(1):61-8. doi: 10.1016/s0009-9236(03)00088-2. [PMID: 12844136]
  • Dunia de Miguel, Carmen Burgaleta, Eduardo Reyes, Teresa Pascual. Capillary whole blood testing by a new portable monitor. Comparison with standard determination of the international normalized ratio. American journal of clinical pathology. 2003 Jul; 120(1):28-33. doi: 10.1309/604p-8d3j-7q3g-aadr. [PMID: 12866369]
  • Ana Martin-Suarez, Drury Rudolph Atencio, Francisco González Lopez, María Santos, Aránzazu Zarzuelo, María Eugenia Mendez, Ignacio Alberca, José Martínez Lanao. Pharmacokinetic study of the digoxin-acenocoumarol interaction in rabbits. Biological & pharmaceutical bulletin. 2003 Jun; 26(6):813-7. doi: 10.1248/bpb.26.813. [PMID: 12808292]
  • J M Alvarez Gutiérrez, J D López-Torres Hidalgo, P Galdón Blesa, E M García Ruiz, F Naharro de Mora. [Pharmacological interactions of statins]. Atencion primaria. 2003 Mar; 31(4):222-6. doi: 10.1016/s0212-6567(03)79163-x. [PMID: 12681161]
  • Armando D'Angelo, Patrizia Della Valle, Luciano Crippa, Annalisa Fattorini, Elisabetta Pattarini, Silvana Viganò D'Angelo. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment. Haematologica. 2002 Oct; 87(10):1074-80. doi: NULL. [PMID: 12368163]
  • J B Schnog, M R Mac Gillavry, R A Rojer, J C M Meijers, R Fijnheer, H ten Cate, D P M Brandjes, A J Duits. No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease. American journal of hematology. 2002 Sep; 71(1):53-5. doi: 10.1002/ajh.10178. [PMID: 12221677]